TRPA1 as an analgesic target

by Christopher M CM Fanger, Donato del Camino, Magdalene MM Moran
Open Drug Discov. J ()


Humans have cultivated chili peppers for over 5,000 years. For more than 1,000 years extracts from these plants have been used medicinally in the treatment of various forms of pain. As a result, pain researchers have had a long- standing interest in the molecular identity of the receptor for capsaicin, the chemical that produces the sensation of heat from “hot” peppers. When the Julius lab published that TRPV1 is the protein that confers capsaicin responsiveness [1], there was already significant investigation of this target in the pharmaceutical community. The future of TRPV1 as an analgesic target is currently uncertain because inhibiting TRPV1 attenuates patients' ability to sense damaging heat [2, 3] and because concerns have arisen that TRPV1 antagonists cause a transient hyperthermia. However, this interest in TRPV1 has spurred interest in a variety of other TRP channels in the pain area. As the receptor for mustard oil and other noxious compounds that cause pain, TRPA1 in particular has emerged as a promising target. Recent data suggest that TRPA1 is a broad chemosensor, activated by reactive chemicals that are encountered exogenously and by compounds such as hydrogen peroxide that are endogenously produced during inflammation or tissue damage. In this review, we explore the rationale surrounding the use of TRPA1 as an analgesic target and discuss the unique challenges that face those developing antagonists.

Cite this document (BETA)

Readership Statistics

19 Readers on Mendeley
by Discipline
by Academic Status
32% Ph.D. Student
16% Student (Master)
16% Other Professional


Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in